Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Lemke JR, Eoli A, Krey I, Popp B, Strehlow V, Wittekind DA, Vuorinen AL, Aldhalaan HM, Baer S, de Saint Martin A, Hammer TB, Herman I, Hornemann F, Ingebrigtsen T, Lederer D, Lesca G, Marafie D, Mathot M, Rosenfeld JA, Møller RS, Schelhaas HJ, Stillman C, Orsini A, Patel AD, Piard J, Veggiotti P, Vlaskamp DRM, Weckhuysen S, Traynelis SF, Benke TA, Heyne HO, Syrbe S

Open source

DOI
10.1038/s41380-025-03442-x
Published
2026 Feb
Container
Molecular psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41380-025-03442-x,
  title = {Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.},
  author = {Lemke JR and Eoli A and Krey I and Popp B and Strehlow V and Wittekind DA and Vuorinen AL and Aldhalaan HM and Baer S and de Saint Martin A and Hammer TB and Herman I and Hornemann F and Ingebrigtsen T and Lederer D and Lesca G and Marafie D and Mathot M and Rosenfeld JA and Møller RS and Schelhaas HJ and Stillman C and Orsini A and Patel AD and Piard J and Veggiotti P and Vlaskamp DRM and Weckhuysen S and Traynelis SF and Benke TA and Heyne HO and Syrbe S},
  year = {2026},
  journal = {Molecular psychiatry},
  doi = {10.1038/s41380-025-03442-x},
  url = {https://doi.org/10.1038/s41380-025-03442-x}
}

RIS

TY  - JOUR
TI  - Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.
AU  - Lemke JR
AU  - Eoli A
AU  - Krey I
AU  - Popp B
AU  - Strehlow V
AU  - Wittekind DA
AU  - Vuorinen AL
AU  - Aldhalaan HM
AU  - Baer S
AU  - de Saint Martin A
AU  - Hammer TB
AU  - Herman I
AU  - Hornemann F
AU  - Ingebrigtsen T
AU  - Lederer D
AU  - Lesca G
AU  - Marafie D
AU  - Mathot M
AU  - Rosenfeld JA
AU  - Møller RS
AU  - Schelhaas HJ
AU  - Stillman C
AU  - Orsini A
AU  - Patel AD
AU  - Piard J
AU  - Veggiotti P
AU  - Vlaskamp DRM
AU  - Weckhuysen S
AU  - Traynelis SF
AU  - Benke TA
AU  - Heyne HO
AU  - Syrbe S
PY  - 2026
JO  - Molecular psychiatry
DO  - 10.1038/s41380-025-03442-x
UR  - https://doi.org/10.1038/s41380-025-03442-x
ER  - 

APA

JR, L., A, E., I, K., B, P., V, S., DA, W., AL, V., HM, A., S, B., A, D. S. M., TB, H., I, H., F, H., T, I., D, L., G, L., D, M., M, M., JA, R., RS, M., HJ, S., C, S., A, O., AD, P., J, P., P, V., DRM, V., S, W., SF, T., TA, B., HO, H., & S, S. (2026). Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.. Molecular psychiatry. https://doi.org/10.1038/s41380-025-03442-x

Source records